1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2017

De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

Curigliano, G., Burstein, H. J., Winer, E. P., Gnant, M., Dubsky, P., Loibl, S., Colleoni, M., M. Regan, M., Piccart-Gebhart, M., Senn, H. J., Thürlimann, B., André, F., Baselga, J., Bergh, J., Bonnefoi, H., Brucker, S. Y., Cardoso, F., Carey, L., Ciruelos, E., Cuzick, J. & 31 others, Denkert, C., Di Leo, A., Ejlertsen, B., Francis, P., Galimberti, V., Garber, J., Gulluoglu, B., Goodwin, P., Harbeck, N., F. Hayes, D., Huang, C. S., Huober, J., Hussein, K., Jassem, J., Jiang, Z., Karlsson, P., Morrow, M., Orecchia, R., Osborne, K. C., Pagani, O., Partridge, A. H., Pritchard, K., Ro, J., Rutgers, E. J. T., Sedlmayer, F., Semiglazov, V., Shao, Z., Smith, I., Toi, M., Viale, G. & on behalf of the Panel Members of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017, Aug 1 2017, In : Annals of Oncology. 28, 8, p. 1700-1712 13 p., mdx308.

Research output: Contribution to journalArticle

Treatment efficacy, adherence, and quality of life among women younger than 35 years in the international breast cancer study group TEXT and SOFT adjuvant endocrine therapy trials

Saha, P., Regan, M. M., Pagani, O., Francis, P. A., Walley, B. A., Ribi, K., Bernhard, J., Luo, W., Gómez, H. L., Burstein, H. J., Parmar, V., Torres, R., Stewart, J., Bellet, M., Perelló, A., Dane, F., Moreira, A., Vorobiof, D., Nottage, M., Price, K. N. & 6 others, Coates, A. S., Goldhirsch, A., Gelber, R. D., Colleoni, M., Fleming, G. F. & SOFT and TEXT Investigators and International Breast Cancer Study Group, Sep 20 2017, In : Journal of Clinical Oncology. 35, 27, p. 3113-3122 10 p.

Research output: Contribution to journalArticle

2016

Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT Trials

Regan, M. M., Francis, P. A., Pagani, O., Fleming, G. F., Walley, B. A., Viale, G., Colleoni, M., Láng, I., Gómez, H. L., Tondini, C., Pinotti, G., Price, K. N., Coates, A. S., Goldhirsch, A. & Gelber, R. D., Jul 1 2016, In : Journal of Clinical Oncology. 34, 19, p. 2221-2230 10 p.

Research output: Contribution to journalArticle

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial

Ribi, K., Luo, W., Bernhard, J., Francis, P. A., Burstein, H. J., Ciruelos, E., Bellet, M., Pavesi, L., Lluch, A., Visini, M., Parmar, V., Tondini, C., Kerbrat, P., Perelló, A., Neven, P., Torres, R., Lombardi, D., Puglisi, F., Karlsson, P., Ruhstaller, T. & 7 others, Colleoni, M., Coates, S. G. A. S., Goldhirsch, A., Price, K. N., Gelber, R. D., Regan, M. & Fleming, G. F., May 10 2016, In : Journal of Clinical Oncology. 34, 14, p. 1601-10 10 p.

Research output: Contribution to journalArticle

Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials I to V

Colleoni, M., Sun, Z., Price, K. N., Karlsson, P., Forbes, J. F., Thürlimann, B., Gianni, L., Castiglione, M., Gelber, R. D., Coates, A. S. & Goldhirsch, A., Mar 20 2016, In : Journal of Clinical Oncology. 34, 9, p. 927-935 9 p.

Research output: Contribution to journalArticle

Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer

Pruneri, G., Vingiani, A., Bagnardi, V., Rotmensz, N., De Rose, A., Palazzo, A., Colleoni, M. A., Goldhirsch, A. & Viale, G., Feb 1 2016, In : Annals of Oncology. 27, 2, p. 249-256 8 p., mdv571.

Research output: Contribution to journalArticle

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): Final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

Cristofanilli, M., Turner, N. C., Bondarenko, I., Ro, J., Im, S. A., Masuda, N., Colleoni, M., DeMichele, A., Loi, S., Verma, S., Iwata, H., Harbeck, N., Zhang, K., Theall, K. P., Jiang, Y., Bartlett, C. H., Koehler, M. & Slamon, D., 2016, (Accepted/In press) In : The Lancet Oncology.

Research output: Contribution to journalArticle

Low-dose oral cyclophosphamide and methotrexate maintenance for hormone receptor-negative early breast cancer: International Breast Cancer Study Group Trial 22-00

Colleoni, M., Gray, K. P., Gelber, S., Láng, I., Thürlimann, B., Gianni, L., Abdi, E. A., Gomez, H. L., Linderholm, B. K., Puglisi, F., Tondini, C., Kralidis, E., Eniu, A., Cagossi, K., Rauch, D., Chirgwin, J., Gelber, R. D., Regan, M. M., Coates, A. S., Price, K. N. & 2 others, Viale, G. & Goldhirsch, A., Oct 1 2016, In : Journal of Clinical Oncology. 34, 28, p. 3400-3408 9 p.

Research output: Contribution to journalArticle

Neoadjuvant nab-paclitaxel in breast cancer: Trial results and patient care

Colleoni, M., Mar 1 2016, In : The Lancet Oncology. 17, 3, p. 265-266 2 p.

Research output: Contribution to journalArticle

Oral chemotherapy in advanced breast cancer: expert perspectives on its role in clinical practice

Cardoso, F., Colleoni, M., Di Leo, A., Francia, G., Gennari, A., Gligorov, J. & Llombart, A., Jun 1 2016, In : Cancer Treatment Communications. 6, p. S1-S10

Research output: Contribution to journalArticle

Palbociclib in combination with fulvestrant in women with hormone receptor-positive/HER2-negative advanced metastatic breast cancer: Detailed safety analysis from a multicenter, randomized, placebo-controlled, phase III study (PALOMA-3)

Verma, S., Bartlett, C. H., Schnell, P., DeMichele, A. M., Loi, S., Ro, J., Colleoni, M., Iwata, H., Harbeck, N., Cristofanilli, M., Zhang, K., Thiele, A., Turner, N. C. & Rugo, H. S., Oct 1 2016, In : Oncologist. 21, 10, p. 1165-1175 11 p.

Research output: Contribution to journalArticle

Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VII

Karlsson, P., Cole, B. F., Price, K. N., Gelber, R. D., Coates, A. S., Goldhirsch, A., Castiglione, M., Colleoni, M. & Gruber, G., Oct 1 2016, In : International Journal of Radiation Oncology Biology Physics. 96, 2, p. 273-279 7 p.

Research output: Contribution to journalArticle

Treatment adherence and its impact on Disease-Free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequence

Chirgwin, J. H., Giobbie-Hurder, A., Coates, A. S., Price, K. N., Ejlertsen, B., Debled, M., Gelber, R. D., Goldhirsch, A., Smith, I., Rabaglio, M., Forbes, J. F., Neven, P., Láng, I., Colleoni, M. & Thürlimann, B., Jul 20 2016, In : Journal of Clinical Oncology. 34, 21, p. 2452-2459 8 p.

Research output: Contribution to journalArticle

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00

Pruneri, G., Gray, K. P., Vingiani, A., Viale, G., Curigliano, G., Criscitiello, C., Láng, I., Ruhstaller, T., Gianni, L., Goldhirsch, A., Kammler, R., Price, K. N., Cancello, G., Munzone, E., Gelber, R. D., Regan, M. M. & Colleoni, M., Jul 1 2016, In : Breast Cancer Research and Treatment. 158, 2, p. 323-331 9 p.

Research output: Contribution to journalArticle

2015

Adjuvant ovarian suppression in premenopausal breast cancer

Francis, P. A., Regan, M. M., Fleming, G. F., Láng, I., Ciruelos, E., Bellet, M., Bonnefoi, H. R., Climent, M. A., Da Prada, G. A., Burstein, H. J., Martino, S., Davidson, N. E., Geyer, C. E., Walley, B. A., Coleman, R., Kerbrat, P., Buchholz, S., Ingle, J. N., Winer, E. P. M., Rabaglio-Poretti, M. & 9 others, Maibach, R., Ruepp, B., Giobbie-Hurder, A., Price, K. N., Colleoni, M., Viale, G., Coates, A. S., Goldhirsch, A. & Gelber, R. D., Jan 1 2015, In : New England Journal of Medicine. 372, 5, p. 436-446 11 p.

Research output: Contribution to journalArticle

Adjuvant ovarian suppression in premenopausal breast cancer

Francis, P. A., Regan, M. M., Fleming, G. F., Láng, I., Ciruelos, E., Bellet, M. M., Bonnefoi, H. R., Climent, M. A., Da Prada, G. A., Burstein, H. J., Martino, S., Davidson, N. E., Geyer, C. E., Walley, B. A., Coleman, R., Kerbrat, P., Buchholz, S., Ingle, J. N., Winer, E. P. M., Rabaglio-Poretti, M. & 10 others, Maibach, R., Ruepp, B., Giobbie-Hurder, A., Price, K. N., Colleoni, M., Viale, G., Coates, A. S., Goldhirsch, A., Gelber, R. D. & Torrisi, R. M. C., 2015, In : New England Journal of Medicine. 372, 5, p. 436-446 11 p.

Research output: Contribution to journalArticle

Aromatase inhibitors versus tamoxifen in early breast cancer: Patient-level meta-analysis of the randomised trials

Bradley, R., Burrett, J., Clarke, M., Davies, C., Duane, F., Evans, V., Gettins, L., Godwin, J., Gray, R., Liu, H., McGale, P., MacKinnon, E., McHugh, T., James, S., Morris, P., Pan, H., Peto, R., Read, S., Taylor, C., Wang, Y. & 31 others, Wang, Z., Dowsett, M., Forbes, J. F., Ingle, J., Coates, A., Cuzick, J., Gnant, M., Aihara, T., Bliss, J., Boccardo, F., Coombes, R. C., Dubsky, P., Kaufmann, M., Kilburn, L., Perrone, F., Rea, D., Thürlimann, B., Van De Velde, C., Baum, M., Buzdar, A., Sestak, I., Markopoulos, C., Fesl, C., Jakesz, R., Colleoni, M., Gelber, R., Regan, M., Gianni, L., Goldhirsch, A., Viale, G. & Early Breast Cancer Trialists’ Collaborative Group, Oct 3 2015, In : The Lancet. 386, 10001, p. 1341-1352 12 p.

Research output: Contribution to journalArticle

Clinical overview of metronomic chemotherapy in breast cancer

Munzone, E. & Colleoni, M., Nov 1 2015, In : Nature Reviews Clinical Oncology. 12, 11, p. 631-644 14 p.

Research output: Contribution to journalArticle

Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast Cancer

Colleoni, M. & Munzone, E., Jul 16 2015, In : Drugs. 75, 12, p. 1311-1321 11 p.

Research output: Contribution to journalArticle

Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial

Munzone, E., Giobbie-Hurder, A., Gusterson, B. A., Mallon, E., Viale, G., Thürlimann, B., Ejlertsen, B., MacGrogan, G., Bibeau, F., Lelkaitis, G., Price, N., Gelber, R. D., Coates, A. S., Goldhirsch, A. & Colleoni, M., Dec 1 2015, In : Annals of Oncology. 26, 12, p. 2442-2449 8 p.

Research output: Contribution to journalArticle

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): A combined analysis of two phase 3 randomised trials

Bernhard, J., Luo, W., Ribi, K., Colleoni, M., Burstein, H. J., Tondini, C., Pinotti, G., Spazzapan, S., Ruhstaller, T., Puglisi, F., Pavesi, L., Parmar, V., Regan, M. M., Pagani, O., Fleming, G. F., Francis, P. A., Price, K. N., Coates, A. S., Gelber, R. D., Goldhirsch, A. & 1 others, Walley, B. A., Jul 1 2015, In : The Lancet Oncology. 16, 7, p. 848-858 11 p.

Research output: Contribution to journalArticle

Picking the optimal endocrine adjuvant treatment for pre-menopausal women

Colleoni, M. & Munzone, E., Nov 1 2015, In : Breast. 24, p. S11-S14

Research output: Contribution to journalArticle

Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials

Regan, M. M., Pagani, O., Francis, P. A., Fleming, G. F., Walley, B. A., Kammler, R., Dell’Orto, P., Russo, L., Szőke, J., Doimi, F., Villani, L., Pizzolitto, S., Öhlschlegel, C., Sessa, F., Peg Cámara, V., Rodríguez Peralto, J. L., MacGrogan, G., Colleoni, M., Goldhirsch, A., Price, K. N. & 3 others, Coates, A. S., Gelber, R. D. & Viale, G., Nov 1 2015, In : Breast Cancer Research and Treatment. 154, 2, p. 275-286 12 p.

Research output: Contribution to journalArticle

Relative effectiveness of letrozole compared with tamoxifen for patients with lobular carcinoma in the BIG 1-98 Trial

Filho, O. M., Giobbie-Hurder, A., Mallon, E., Gusterson, B., Viale, G., Winer, E. P., Thürlimann, B., Gelber, R. D., Colleoni, M., Ejlertsen, B., Debled, M., Price, K. N., Regan, M. M., Coates, A. S. & Goldhirsch, A., Sep 1 2015, In : Journal of Clinical Oncology. 33, 25, p. 2772-2778 7 p.

Research output: Contribution to journalArticle

Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Coates, A. S., Winer, E. P., Goldhirsch, A., Gelber, R. D., Gnant, M., Piccart-Gebhart, M. J., Thürlimann, B., Senn, H. J., André, F., Baselga, J., Bergh, J., Bonnefoi, H., Burstein, H., Cardoso, F., Castiglione-Gertsch, M., Colleoni, M., Curigliano, G., Davidson, N. E., Leo, A. D., Ejlertsen, B. & 29 others, Forbes, J. F., Galimberti, V., Goodwin, P., Harbeck, N., Hayes, D. F., Huober, J., Hudis, C. A., Ingle, J. N., Jassem, J., Jiang, Z., Karlsson, P., Morrow, M., Orecchia, R., Kent Osborne, C., Partridge, A. H., de la Peña, L., Pritchard, K. I., Rutgers, E. J. T., Sedlmayer, F., Semiglazov, V., Shao, Z. M., Smith, I., Toi, M., Tutt, A., Viale, G., von Minckwitz, G., Watanabe, T., Whelan, T. & Xu, B., 2015, In : Annals of Oncology. 26, 8, p. 1533-1546 14 p.

Research output: Contribution to journalArticle

2014

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

Pagani, O., Regan, M. M., Walley, B. A., Fleming, G. F., Colleoni, M., Láng, I., Gomez, H. L., Tondini, C., Burstein, H. J., Perez, E. A., Ciruelos, E., Stearns, V., Bonnefoi, H. R., Martino, S., Geyer, C. E., Pinotti, G., Puglisi, F., Crivellari, D., Ruhstaller, T., Winer, E. P. & 13 others, Rabaglio-Poretti, M., Maibach, R., Ruepp, B., Giobbie-Hurder, A., Price, K. N., Bernhard, J., Luo, W., Ribi, K., Viale, G., Coates, A. S., Gelber, R. D., Goldhirsch, A. & Francis, P. A., 2014, In : New England Journal of Medicine. 371, 2, p. 107-118 12 p.

Research output: Contribution to journalArticle

Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan

Bouche, G., André, N., Banavali, S., Berthold, F., Berruti, A., Bocci, G., Brandi, G., Cavallaro, U., Cinieri, S., Colleoni, M., Curigliano, G., Di Desidero, T., Eniu, A., Fazio, N., Kerbel, R., Hutchinson, L., Ledzewicz, U., Munzone, E., Pasquier, E., Scharovsky, O. G. & 4 others, Shaked, Y., Štěrba, J., Villalba, M. & Bertolini, F., Sep 9 2014, In : ecancermedicalscience. 8, 463.

Research output: Contribution to journalArticle

Metronomic therapy and breast cancer: A systematic review

Montagna, E., Cancello, G., Dellapasqua, S., Munzone, E. & Colleoni, M., 2014, In : Cancer Treatment Reviews. 40, 8, p. 942-950 9 p.

Research output: Contribution to journalArticle

Neoadjuvant chemotherapy for breast cancer: Any progress?

Colleoni, M. & Goldhirsch, A., Feb 2014, In : The Lancet Oncology. 15, 2, p. 131-132 2 p.

Research output: Contribution to journalArticle